Get all your news in one place.
100's of premium titles.
One app.
Start reading
MarketBeat
MarketBeat
MarketBeat

EXPLAINED: Neuropace q1 earnings call highlights | Rare Historical Photos

NeuroPace (NASDAQ:NPCE) raised its 2026 revenue outlook after reporting first-quarter results that management said reflected continued demand for its RNS System and improving commercial execution across epilepsy treatment centers.

The company reported total revenue of $22.1 million for the first quarter of 2026. Excluding DIXI Medical, revenue was $22 million, with RNS System revenue of $21.7 million. Chief Financial Officer Patrick Williams said non-GAAP revenue excluding DIXI Medical rose 20.1% from $18.3 million in the prior-year quarter, while RNS System revenue increased 19.5% from $18.2 million in the first quarter of 2025.

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.